
Number of publications published per year by Kato, Michio. (Source : PubMed)

Distribution of publications types for Kato, Michio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
High-density lipoprotein cholesterol improves the model for end-stage liver disease scoring system for prognostic prediction of acute liver failure.
Scand. J. Gastroenterol.
2010;45;4
Premature Terminal Exhaustion of Friend Virus-Specific Effector CD8+ T Cells by Rapid Induction of Multiple Inhibitory Receptors.
J. Immunol.
2010
Use of magnifying endoscopy to identify early esophageal adenocarcinoma in ectopic gastric mucosa of the cervical esophagus.
Clin. Gastroenterol. Hepatol.
2010
Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis.
Blood
2010
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.
J. Exp. Med.
2010;207;3
FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion.
J. Hum. Genet.
2010
Model analysis of the concentration-dependent permeability of P-gp substrates.
Pharm. Res.
2010;27;3
Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan.
Int. J. Clin. Oncol.
2010
Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging During Laparoscopic Surgery in Gastric Cancer.
Annals of surgical oncology
2010
Enhancement of effector CD8(+) T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Immunology
2010
[ See timeline ] [ See all publications ]
means that Kato, Michio has 36 papers cited a least 36 times - methodology
Department of Immunology and.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.